Nile Pharmaceuticals board approves doubling issued capital to EGP 1 billion
Reuters reports the board of Nile Pharmaceuticals approved lifting issued capital from EGP 500 million to EGP 1 billion, a doubling of the share base.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to Reuters, the board of Egypt's Nile Pharmaceuticals and Chemical Industries has approved an increase in the company's issued capital. The figure rises from EGP 500 million to EGP 1 billion, so the capital doubles.
The decision is a board-level corporate step. The report does not give details on the timing or the method of the share issue.
why it matters
A decision like this mainly matters to the company's shareholders and investors, since it changes the capital structure and may affect the number of shares outstanding. For the wider market and other assets, the news has little relevance.
tags
instruments
sources
- Nile Pharmaceuticals Board Approves Issued Capital Increase — Reuters, 1 November 2026 at 08:59 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗